Optimal Fluid Resuscitation for Trauma Patients

The purpose of this study is to determine if the overall fluid requirements for the first 24 hours after admission will be reduced with Hextend versus a standard of care crystalloid resuscitation fluid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Trauma Wounds and Injuries

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ryder Trauma Center

Miami, Florida, 33136, United States

About this study

Following severe multi-system traumatic injury, the first 24 hours of standard resuscitation fluid will be either Hextend or crystalloid depending upon attending preference. No tests or interventions will be performed for research purposes.

Data will be collected prospectively from patient medical records and attending clinicians to monitor fluid requirements, hemodynamics and outcome.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Greater than or equal to 18 years old and less than 65 years old
Admission with multi-system traumatic injury
Admission to the intensive care unit

Exclusion criteria

Less than 18 or greater than 65 years old
Pregnant or lactating
No fluid resuscitation

Treatment and study plan

Primary outcomes

Mortality

Time frame: From hospital arrival up to an average of 3.5 weeks

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Registry information

Important dates

Study start: 2007
Primary completion: 2010
Study completion: 2010
First posted: Sep 10, 2007
Registry last updated: Feb 22, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed